SELLAS Life Sciences Group, Inc. (SLS)

SLS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18.52	2.63	17.23	21.46	35.4	7.38
Cash & Cash Equivalents	18.52	2.63	17.23	21.46	35.4	7.38
Cash Growth	-22.86%	-84.73%	-19.72%	-39.40%	379.90%	35.33%
Other Current Assets	2.99	0.54	0.53	1.59	1.52	0.87
Total Current Assets	21.5	3.17	17.76	23.04	36.93	8.24
Property, Plant & Equipment	0.75	0.86	0.87	0.72	0.9	0.22
Goodwill and Intangibles	1.91	1.91	1.91	1.91	1.91	1.91
Other Long-Term Assets	0.27	0.28	0.4	0.59	6.31	6.24
Total Long-Term Assets	2.93	3.05	3.19	3.23	9.12	8.37
Total Assets	24.43	6.22	20.94	26.28	46.05	16.61
Accounts Payable	7.41	5.64	3.36	2.14	4.66	3.9
Deferred Revenue	0	0	0	0	5.6	0
Current Debt	0.49	0.45	0.37	0.2	0.17	0.22
Other Current Liabilities	6.54	7.65	11.79	2.64	1.91	1.17
Total Current Liabilities	14.44	13.74	15.52	4.98	12.34	5.29
Long-Term Debt	0.31	0.46	0.57	0.61	0.83	0
Other Long-Term Liabilities	0	0	0	0.34	4.93	5.23
Total Long-Term Liabilities	0.31	0.46	0.58	0.95	5.75	5.23
Total Liabilities	14.75	14.2	16.09	5.93	18.09	10.52
Total Debt	0.8	0.91	0.95	0.81	0.99	0.22
Debt Growth	-5.65%	-4.13%	16.96%	-18.47%	356.68%	-
Retained Earnings	-226.81	-217.24	-179.9	-138.6	-117.9	-101.15
Shareholders' Equity	9.68	-7.98	4.85	20.35	27.96	6.09
Net Cash / Debt	17.71	1.72	16.28	20.65	34.41	7.16
Net Cash / Debt Growth	-23.49%	-89.41%	-21.15%	-40.00%	380.60%	31.35%
Net Cash Per Share	0.40	0.06	0.84	1.33	4.31	2.80
Working Capital	7.06	-10.56	2.24	18.06	24.59	2.95
Book Value Per Share	0.22	-0.29	0.25	1.31	3.50	2.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).